TR200200673T2 - Rinovirüs enfeksiyonlarında csaıd'lerin kullanılması - Google Patents

Rinovirüs enfeksiyonlarında csaıd'lerin kullanılması

Info

Publication number
TR200200673T2
TR200200673T2 TR2002/00673T TR200200673T TR200200673T2 TR 200200673 T2 TR200200673 T2 TR 200200673T2 TR 2002/00673 T TR2002/00673 T TR 2002/00673T TR 200200673 T TR200200673 T TR 200200673T TR 200200673 T2 TR200200673 T2 TR 200200673T2
Authority
TR
Turkey
Prior art keywords
csaids
rhinovirus infections
rhinovirus
infections
symptoms
Prior art date
Application number
TR2002/00673T
Other languages
English (en)
Turkish (tr)
Inventor
B. Dillon Susan
D. Griego Sandra
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of TR200200673T2 publication Critical patent/TR200200673T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
TR2002/00673T 1999-09-17 2000-09-15 Rinovirüs enfeksiyonlarında csaıd'lerin kullanılması TR200200673T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15449499P 1999-09-17 1999-09-17

Publications (1)

Publication Number Publication Date
TR200200673T2 true TR200200673T2 (tr) 2002-12-23

Family

ID=22551566

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/00673T TR200200673T2 (tr) 1999-09-17 2000-09-15 Rinovirüs enfeksiyonlarında csaıd'lerin kullanılması

Country Status (17)

Country Link
EP (1) EP1223924A4 (cs)
JP (1) JP2003516314A (cs)
KR (1) KR20020032591A (cs)
CN (1) CN1382044A (cs)
AR (1) AR025691A1 (cs)
AU (1) AU7584500A (cs)
BR (1) BR0014041A (cs)
CA (1) CA2385722A1 (cs)
CO (1) CO5200855A1 (cs)
CZ (1) CZ2002939A3 (cs)
HU (1) HUP0204333A3 (cs)
IL (1) IL148329A0 (cs)
NO (1) NO20021301L (cs)
PL (1) PL363116A1 (cs)
TR (1) TR200200673T2 (cs)
WO (1) WO2001019322A2 (cs)
ZA (1) ZA200202060B (cs)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7301021B2 (en) 1997-07-02 2007-11-27 Smithkline Beecham Corporation Substituted imidazole compounds
US6858617B2 (en) 1998-05-26 2005-02-22 Smithkline Beecham Corporation Substituted imidazole compounds
DE69914357T2 (de) 1998-11-04 2004-11-11 Smithkline Beecham Corp. Pyridin-4-yl oder pyrimidin-4-yl substituierte pyrazine
JP2003514900A (ja) 1999-11-23 2003-04-22 スミスクライン・ビーチャム・コーポレイション ＣＳＢＰ／ｐ３８キナーゼ阻害剤としての３，４−ジヒドロ−（１Ｈ）−キナゾリン−２−オン化合物
EP1233950B1 (en) 1999-11-23 2005-10-05 Smithkline Beecham Corporation 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/P39 kINASE INHIBITORS
ATE281439T1 (de) 1999-11-23 2004-11-15 Smithkline Beecham Corp 3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p38-kinase-inhibitoren
US7235551B2 (en) 2000-03-02 2007-06-26 Smithkline Beecham Corporation 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
AU2002248269A1 (en) * 2000-10-19 2002-08-12 Smithkline Beecham Corporation Use of p38 inhibitors for the treatment of inflammation-enhanced cough
CN100525768C (zh) 2000-10-23 2009-08-12 史密丝克莱恩比彻姆公司 新化合物
EP1490025B1 (en) * 2002-03-20 2008-02-13 Elan Pharma International Limited Nanoparticulate compositions of map kinase inhibitors
CA2479520A1 (en) * 2002-04-05 2003-10-16 Birgit Jung P38 kinase inhibitors for treating mucus hypersecretion_
ES2278170T3 (es) * 2002-07-09 2007-08-01 BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG Composiciones farmaceuticas de anticolinergicos e inhibidores de la quinasa p38 en el tratamiento de enfermedades respiratorias.
JP4593953B2 (ja) * 2004-03-30 2010-12-08 杏林製薬株式会社 ライノウイルス感染症の予防薬
MX2007001561A (es) * 2004-08-04 2007-04-16 Schering Corp Formulacion farmaceutica que comprende pleconaril para tratamiento de enfermedades de vias aereas.
MY145343A (en) 2005-03-25 2012-01-31 Glaxo Group Ltd Novel compounds
JP5558458B2 (ja) * 2008-03-20 2014-07-23 タノメド・アクチボラゲット 普通感冒の治療用の医薬の製造における物質の使用
GB0905955D0 (en) 2009-04-06 2009-05-20 Respivert Ltd Novel compounds
WO2011035128A1 (en) * 2009-09-17 2011-03-24 Mutual Pharmaceutical Company, Inc. Method of treating asthma with antiviral agents
GB201010193D0 (en) 2010-06-17 2010-07-21 Respivert Ltd Medicinal use
GB201010196D0 (en) * 2010-06-17 2010-07-21 Respivert Ltd Methods
US11730760B2 (en) 2011-04-01 2023-08-22 The Bioregentech Institute, Inc. Laser assisted wound healing protocol and system
US11389663B2 (en) 2011-04-01 2022-07-19 Bioregentech, Inc. Laser assisted wound healing protocol and system
GB201611712D0 (en) 2016-07-02 2016-08-17 Hvivo Services Ltd Methods and compounds for the treatment or prevention of severe or persistent influenza
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
BR112020006677A2 (pt) 2017-10-05 2020-10-06 Fulcrum Therapeutics, Inc. uso de inibidores p38 para reduzir a expressão de dux4
GB201721793D0 (en) * 2017-12-22 2018-02-07 Hvivo Services Ltd Methods and compunds for the treatment or prevention of hypercytokinemia and severe influenza
WO2021216754A1 (en) * 2020-04-21 2021-10-28 Spring Discovery, Inc. Use of p38 mapk inhibitors for prevention and treatment of aging and aging-related disorders and for boosting an immune system

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3927216A (en) * 1971-06-01 1975-12-16 Icn Pharmaceuticals 1,2,4-Triazol E-3-carboxamides for inhibiting virus infections
US3984396A (en) * 1971-06-01 1976-10-05 Icn Pharmaceuticals, Inc. 1-(β,-D-ribofuranosyl)-1,2,4-triazole acid esters
US5656644A (en) * 1994-07-20 1997-08-12 Smithkline Beecham Corporation Pyridyl imidazoles
IL118544A (en) * 1995-06-07 2001-08-08 Smithkline Beecham Corp History of imidazole, the process for their preparation and the pharmaceutical preparations containing them
AP9700912A0 (en) * 1996-01-11 1997-01-31 Smithkline Beecham Corp Novel cycloalkyl substituted imidazoles
WO2000040243A1 (en) * 1999-01-08 2000-07-13 Smithkline Beecham Corporation Novel compounds

Also Published As

Publication number Publication date
CA2385722A1 (en) 2001-03-22
PL363116A1 (en) 2004-11-15
AU7584500A (en) 2001-04-17
KR20020032591A (ko) 2002-05-03
CZ2002939A3 (cs) 2002-11-13
CN1382044A (zh) 2002-11-27
NO20021301D0 (no) 2002-03-15
NO20021301L (no) 2002-05-16
EP1223924A4 (en) 2004-07-14
JP2003516314A (ja) 2003-05-13
AR025691A1 (es) 2002-12-11
EP1223924A2 (en) 2002-07-24
CO5200855A1 (es) 2002-09-27
WO2001019322A2 (en) 2001-03-22
HUP0204333A3 (en) 2004-07-28
BR0014041A (pt) 2003-07-15
ZA200202060B (en) 2003-05-28
IL148329A0 (en) 2002-09-12
HUP0204333A2 (en) 2003-05-28
WO2001019322A3 (en) 2001-10-04

Similar Documents

Publication Publication Date Title
TR200200673T2 (tr) Rinovirüs enfeksiyonlarında csaıd'lerin kullanılması
TR199800815A2 (en) S�lfonilaminokarbonasitler.
TR199802693T2 (xx) De�i�tirilmi� 3,5-difenil-1,2,4-triazoller ve eczasal metal kelatorlar olarak kullan�m�.
TR200000928T2 (tr) Yeni kombinasyon.
TR200100805T2 (tr) Tetrahidropiridoeterler
DK0970095T3 (da) Hidtil ukendte benzimidazolinhibitorer for fructose-1,6-bisphosphase
ATE299890T1 (de) Inhibitoren von gamma-secretase
NO975747D0 (no) Peptidylheterocykler for anvendelse ved behandling av trombin-relaterte mangler
TR199700732T1 (xx) �nsan l�kosit elastazinin inhibit�rleri olarak yararl� olan prolin t�revleri.
TR200002860T2 (tr) Bir antiviral benzimidazol terkibin yeni kristal formları.
DE69519997D1 (de) Verwendung von bindungsreagenzien gegen cd23 in der behandlung von autoimmunkrankheiten
WO1999020260A3 (en) The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function
IT1285770B1 (it) Composti corticoidei
NO934218L (no) Inhibitorer av cathepsin g og elastase for forhindring av bindevevsned-brytning
ATE275143T1 (de) Verbindungen
TR199800841A2 (xx) �kame edilmi� 6- ve 7-aminotetrahidroisokinolinkarbon asitleri.
AP2000001761A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
TR200200246T2 (tr) Nezle ve grip benzeri hastalıklar ile ilişkilendirilen semptomlardan korunma ve bunların tedavisi ile ilgili bileşim.
BR0012675A (pt) Uso de inibidores de il-18
DE69531459D1 (de) Elatase-inhibitoren
CY1107039T1 (el) Αναστολεις τριπεπτιδυλ πεπτιδασης
TR199802270A2 (xx) S�lfonamid-ikame etmi� anelize 5-halka-bile�ikleri.
FR2765214B1 (fr) Traitement de granulat par un latex anti-desenrobage
BR0009289A (pt) Uso de inibidores da vasopeptidase para tratar angina pectoris
GB9920674D0 (en) Treatment of conjunctivitis